Labetalol Hydrochloride Injection
Product Images NDC 0143-9623

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 0143-9623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Labetalol Hydrochloride Injection Usp 1)

Structural Formula (Labetalol Hydrochloride Injection Usp 1)
Chemical structure of Labetalol Hydrochloride depicted as a molecular diagram showing the arrangement of atoms, including benzene rings and functional groups, with the hydrochloride indicated.*
FDA Label Image

Labetalol Hydrochloride 20 mL Vial Label (Labetalol Hydrochloride Injection Usp 2)

Labetalol Hydrochloride 20 mL Vial Label (Labetalol Hydrochloride Injection Usp 2)
Label for Labetalol Hydrochloride Injection 5 mg/mL (100 mg/20 mL), a sterile intravenous solution in a multiple dose vial. The label displays the proprietary name Labetalol, concentration, volume, route of administration, and storage instructions. The labeler is Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Labetalol Hydrochloride 40 mL Vial Label (Labetalol Hydrochloride Injection Usp 3)

Labetalol Hydrochloride 40 mL Vial Label (Labetalol Hydrochloride Injection Usp 3)
Label for Labetalol Hydrochloride Injection USP showing 5 mg/mL strength in a 20 mg/40 mL (5 mg/mL) concentration. This intravenous injection is supplied in a 40 mL multiple dose vial. The label states the product must be used for intravenous injection only and is labeled by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Labetalol Hydrochloride Injection Usp 4

Labetalol Hydrochloride Injection Usp 4
Label for Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL) for intravenous use. The label states it is a 20 mL multiple dose vial, sterile, and intended for intravenous injection only. Manufactured by Hikma FarmacĂȘutica in Portugal and distributed by West-Ward, Eatontown, NJ.*
FDA Label Image

Labetalol Hydrochloride Injection Usp 5

Labetalol Hydrochloride Injection Usp 5
Packaging label for Labetalol Hydrochloride Injection, USP 5 mg/mL in a 40 mL multiple dose vial. The label specifies 200 mg per 40 mL, for intravenous injection only, sterile. Manufactured by Hikma FarmacĂȘutica (Portugal) and distributed by West-Ward in Eatontown, NJ. The label includes storage instructions and a list of inactive ingredients.*
FDA Label Image

Labetalol Hydrochloride Injection Usp 6

Labetalol Hydrochloride Injection Usp 6
A product label for Labetalol Hydrochloride Injection 5 mg/mL by Hikma Pharmaceuticals USA Inc. The label includes a QR code and displays GTIN 00301234567896, serial number 1234567890123, expiration date placeholder 'MMYYYY', and lot number 'ABCDE12345'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.